Introduction Selective Serotonin Reuptake Inhibitors (SSRIs) and triptans are two widely prescribed classes of medications. SSRIs are primarily used to treat depression, anxiety disorders, and other mood disorders, while triptans are commonly prescribed for acute migraine attacks. Both medication classes influence serotonin levels in the brain, albeit through different mechanisms. However, when these drugs are taken together, they can result in an excessive accumulation of serotonin, leading to serotonin syndrome—a rare but potentially life-threatening condition. Although the individual use of SSRIs or triptans is generally safe, their combination requires cautious use due to the risk of this adverse interaction. Serotonin…

Introduction In modern medicine, it’s not uncommon for patients to be prescribed medications from different therapeutic classes to manage multiple conditions simultaneously. Two such commonly prescribed classes are Selective Serotonin Reuptake Inhibitors (SSRIs) for depression and anxiety, and triptans for migraine headaches. Both are effective in their respective domains. However, when used in combination, they can pose a serious risk—serotonin syndrome—a potentially life-threatening condition resulting from excessive serotonergic activity in the central nervous system. While serotonin syndrome is relatively rare, its potential severity demands clinical attention. Understanding the mechanisms behind this interaction, identifying patients at risk, and knowing how to…